Some patients report reduced joint pain while taking GLP-1 receptor agonists
While sommarutide is undoubtedly an exciting potential treatment option, there is still a lack of clear clinical data on the mechanism of action of GLP-1 agonists in NASH, such as whether GLP-1 agonists have a direct, independent role in improving NASH, or simply by improving body weight, insulin resistance, and so on
Noom Microdose GLP-1 Rx Program GLP-1 treatment paired with Noom behavior change Program 17 pounds in 60 days 1 Low-dose GLP-1 designed to reduce observable side effects All-inclusive pricing: clinical care and medication Full access to Nooms program , focused on behavioral change and psychology for lasting results
Results depend on lifestyle factors such as sun exposure, diet, stress, and skincare habits
The disconnect stems from how GLP-1 medications are traditionally prescribed and supported